Arch Biopartners Adds Farris Smith as a Strategic Advisor
October 05, 2022 07:20 ET | Source: Arch Biopartners TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) — Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of innovative technologies and novel therapeutics targeting organ inflammation, welcomed Mr. Farris Smith of Novo Nordisk Canada … Read more